These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2323217)

  • 21. Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol [corrected].
    Aubény E; Peyron R; Turpin CL; Renault M; Targosz V; Silvestre L; Ulmann A; Baulieu EE
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():85-91. PubMed ID: 8574255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to intermittent RU486 in women.
    Spitz IM; Croxatto HB; Salvatierra AM; Heikinheimo O
    Fertil Steril; 1993 May; 59(5):971-5. PubMed ID: 8486197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of abortion in early pregnancy with mifepristone in conjunction with gemeprost.
    Somell C; Olund A
    Acta Obstet Gynecol Scand; 1993 Jan; 72(1):39-42. PubMed ID: 8382430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone analytical and carrier protein alternations following administration of mifepristone (RU 486) for termination of early pregnancy.
    Klinger G; Carol W; Börner A; Michels W; Romero KR
    Exp Clin Endocrinol; 1991 Mar; 97(1):63-7. PubMed ID: 1864315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergency contragestion.
    Schaison G
    Contraception; 1987; 36 Suppl():7-11. PubMed ID: 2445524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical use of RU 486: control of the menstrual cycle and effect on the hypophyseal-adrenal axis].
    Gaillard RC; Herrmann W
    Ann Endocrinol (Paris); 1983; 44(5):345-6. PubMed ID: 6675522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, hormonal and sonographic predictors of successful RU-486-induced abortions.
    Menashe Y; Bider D; Shalev J; Pariente C; Serr DM
    Gynecol Obstet Invest; 1995; 40(2):108-12. PubMed ID: 8575686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone).
    Couzinet B; Le Strat N; Ulmann A; Baulieu EE; Schaison G
    N Engl J Med; 1986 Dec; 315(25):1565-70. PubMed ID: 3785321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of two antiprogestins on early pregnancy in the long-tailed macaque (Macaca fascicularis).
    Tarantal AF; Hendrickx AG; Matlin SA; Lasley BL; Gu QQ; Thomas CA; Vince PM; Van Look PF
    Contraception; 1996 Aug; 54(2):107-15. PubMed ID: 8842588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum human chorionic gonadotropin (hCG) trend within the first few days after medical abortion: a prospective study.
    Pocius KD; Bartz D; Maurer R; Stenquist A; Fortin J; Goldberg AB
    Contraception; 2017 Mar; 95(3):263-268. PubMed ID: 27621046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood loss following induction of early abortion using mifepristone (RU 486) and a prostaglandin analogue (gemeprost).
    Rodger MW; Baird DT
    Contraception; 1989 Oct; 40(4):439-47. PubMed ID: 2582769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Termination of early pregnancy through a combination of the antiprogestin and prostaglandin analogue.
    Maria B; Stampf F; Goepp A; Dubois C
    Eur J Obstet Gynecol Reprod Biol; 1990 Oct; 37(1):35-40. PubMed ID: 2376278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy termination with a high and medium dosage regimen of RU 486.
    Shoupe D; Mishell DR; Brenner PF; Spitz IM
    Contraception; 1986 May; 33(5):455-61. PubMed ID: 3757511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicentre randomized comparative clinical trial of 200 mg RU486 (mifepristone) single dose followed by either 5 mg 9-methylene PGE(2) gel (meteneprost) or 600 microg oral PGE(1) (misoprostol) for termination of early pregnancy within 28 days of missed menstrual period. ICMR Task Force Study. Indian Council of Medical Research.
    Contraception; 2000 Sep; 62(3):125-30. PubMed ID: 11124359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
    Kekkonen R; Lähteenmäki P; Luukkainen T; Tuominen J
    Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy.
    Swahn ML; Ugocsai G; Bygdeman M; Kovacs L; Belsey EM; Van Look PF
    Hum Reprod; 1989 Jan; 4(1):21-8. PubMed ID: 2651472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Termination of early pregnancy with RU 486 (mifepristone) in combination with a prostaglandin analogue (sulprostone).
    Swahn ML; Bygdeman M
    Acta Obstet Gynecol Scand; 1989; 68(4):293-300. PubMed ID: 2694744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reproductive hormones during termination of early pregnancy with mifepristone.
    Somell C; Olund A; Carlström K; Kindahl H
    Gynecol Obstet Invest; 1990; 30(4):224-7. PubMed ID: 2289703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.